Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study

Journal of Health Economics and Outcomes Research
Nirmish ShahHuseyin Yuce

Abstract

Sickle cell disease (SCD) is a life-threatening vascular disease that burdens affected persons physically. SCD-related vaso-occlusive crises (VOCs) are one of the primary causes of morbidity and mortality. Our objective was to examine the epidemiology of pain crises and the relationship between pain crises and major acute complications among SCD patients. Using the Medicaid Analytic Extracts from 2009-2013, patients with SCD were selected and the first clinical claim indicating SCD during the identification period was defined as the index date. Patients were required to have continuous Medicaid enrollment for ≥6 months pre- and 12 months post-index period. Clinical outcomes included mortality, inpatient pain crises, and complications. Cox regressions were applied to examine the relationship between pain crises and deaths or acute complications, respectively. A total of 20 909 patients were included with a mean age of 17.9 years. The rate of VOC events in 100 person-years was 142.20 for adults and 53.91 for pediatric patients. Patients with VOCs were associated with a higher risk for death (hazard ratio=1.56; 95% confidence interval: [1.19-2.05]) or acute complications including acute chest syndrome, stroke, pulmonary embolism, ...Continue Reading

References

Jul 4, 1991·The New England Journal of Medicine·O S PlattT R Kinney
Feb 1, 1992·American Journal of Public Health·J W KriegerJ P LoGerfo
Nov 20, 2002·Journal of Pediatric Hematology/oncology·Carlton DampierPatricia O'Neal
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·Carlton DampierPatricia O'Neal
Feb 27, 2004·The New England Journal of Medicine·Mark T GladwinFrederick P Ognibene
Jan 16, 2008·Annals of Internal Medicine·Wally R SmithSusan D Roseff
Jul 16, 2008·Journal of Clinical Epidemiology·Mary E CharlsonJames P Hollenberg
Dec 24, 2009·American Journal of Hematology·Courtney D FitzhughLaura M De Castro
Jan 18, 2011·Hematology·Wally R Smith, Marshall Scherer
Mar 2, 2013·Public Health Reports·Sophie LanzkronCarlton Haywood
Oct 8, 2013·Blood Reviews·Julie Kanter, Rebecca Kruse-Jarres
Sep 10, 2014·JAMA : the Journal of the American Medical Association·Barbara P YawnJoylene John-Sowah
Apr 29, 2015·JAMA : the Journal of the American Medical Association·Nicolas StettlerNancy B Walczak
Feb 3, 2016·Chest·Enrico M Novelli, Mark T Gladwin
May 14, 2016·Journal of Hematology Research·Amy E SobotaJennifer W Mack

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.